Home > News > Content

Marker Of Heart Failure And Its Application

Feb 16, 2017

Marker of heart failure and its application
Relative to the AMI, heart failure slow evolution, but the prognosis is very poor, a high mortality rate, and came by the progression of cardiovascular disease. Due to the lack of specific clinical manifestations of heart failure, no obvious symptoms and is difficult to diagnose in the early although echocardiography examination has some effect, because of the high prices, the need for professionals to operate, cannot be in the emergency room next to the bed of the shortcomings so that their application is limited. In recent years, the United States and the European society of Cardiology have recommended the use of b-type natriuretic peptide (BNP) as a laboratory evaluation of congestive heart failure. BNP comes mainly from Allen, myocardial cells and ventricular load and stifled wall tension increases will stimulate secretion of BNP. Its weight and heart failure has a positive of the day of the release, because the BNP has cardiac-specific, can help early detection and diagnosis of clinical heart failure. The other hand, the BNP can be used for differential diagnosis of non-breathing difficulties caused by heart failure, in this case BNP does not raise or higher is not always apparent